Advertisement

Advertisement

AMRN Stock Latest News

Amarin Shareholders Reject Dilution, Governance Proposals at AGM

Company AnnouncementsAmarin Shareholders Reject Dilution, Governance Proposals at AGM

Amarin Earnings Call Signals Leaner, Global Growth

PremiumCompany Announcements

Amarin Earnings Call Signals Leaner, Global Growth

1M ago

AMRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

AMRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

1M ago

Amarin Streamlines Board, Updates Director Equity Compensation Plan

PremiumCompany Announcements

Amarin Streamlines Board, Updates Director Equity Compensation Plan

2M ago

Amarin highlights new recommendation for treatment of CV risk

PremiumThe Fly

Amarin highlights new recommendation for treatment of CV risk

2M ago

Amarin to present data in patients at extreme cardiovascular risk

PremiumThe FlyAmarin to present data in patients at extreme cardiovascular risk

3M ago

Amarin’s European Outlook Hinges on Recordati’s VAZKEPA Execution, Raising Commercial and IP Risk

Company Announcements

Amarin’s European Outlook Hinges on Recordati’s VAZKEPA Execution, Raising Commercial and IP Risk

3M ago

Amarin Earnings Call: Cost Cuts, Cash, and Crosswinds

Company Announcements

Amarin Earnings Call: Cost Cuts, Cash, and Crosswinds

3M ago

Amarin highlights recent data published on REDUCE-IT study

PremiumThe Fly

Amarin highlights recent data published on REDUCE-IT study

3M ago

Amarin reports Q4 non-GAAP EPS 1c vs. (2c) last year

PremiumThe Fly

Amarin reports Q4 non-GAAP EPS 1c vs. (2c) last year

3M ago

Amarin CFO says ‘well positioned’ to deliver on 2026 strategic priorities

PremiumThe Fly

Amarin CFO says ‘well positioned’ to deliver on 2026 strategic priorities

3M ago

Amarin issues call to action for American Heart Month

PremiumThe Fly

Amarin issues call to action for American Heart Month

3M ago

AMRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-EarningsAMRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

3M ago

Amarin comments on recent innovations for patients with elevated triglycerides

The Fly

Amarin comments on recent innovations for patients with elevated triglycerides

5M ago

Amarin expects Q4 net revenue $48M-$43M

The Fly

Amarin expects Q4 net revenue $48M-$43M

5M ago

Amarin believes it’s in ‘best position’ to capitalize on opportunities in FY26

PremiumThe Fly

Amarin believes it’s in ‘best position’ to capitalize on opportunities in FY26

5M ago

Amarin announces new post hoc analysis of aspirin use in REDUCE-IT

PremiumThe Fly

Amarin announces new post hoc analysis of aspirin use in REDUCE-IT

7M ago

Amarin Corporation’s Financial Health at Risk Amid Global Trade Uncertainties

PremiumCompany Announcements

Amarin Corporation’s Financial Health at Risk Amid Global Trade Uncertainties

7M ago

Amarin Corporation Reports Q3 2025 Financial Results

PremiumCompany Announcements

Amarin Corporation Reports Q3 2025 Financial Results

7M ago

Amarin Corporation’s Earnings Call Highlights Growth and Challenges

PremiumCompany AnnouncementsAmarin Corporation’s Earnings Call Highlights Growth and Challenges

7M ago

Amarin reports Q3 EPS (2c) vs (6c) last year

The Fly

Amarin reports Q3 EPS (2c) vs (6c) last year

7M ago

Amarin issues statement related to recent action by FDA for fenofibrate drugs

The Fly

Amarin issues statement related to recent action by FDA for fenofibrate drugs

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >